Literature DB >> 27793938

FoxO3a is Essential for the Antiproliferative and Apoptogenic Effects of Sunitinib in MDA-MB231 Cell Line.

Hesham M Korashy1, Osamah M Belali2, Mushtaq A Ansar2, Naif O Alharbi2.   

Abstract

BACKGROUND: Sunitinib (SUN), a tyrosine kinase inhibitor, is a promising treatment for triple-negative breast cancer (TNBC), the most aggressive and fast-growing type of breast cancer. Yet, the protective effect of SUN against TNBC is poorly investigated and the role of Forkhead box type O (FOXO3a) transcription factor is still unknown.
MATERIALS AND METHODS: Cell proliferation was evaluated using the MTT assay. The mRNA and protein expression of apoptotic, oxidative stress and cell cycle genes were determined by real-time polymerase chain reaction (RT-PCR) and western blot analyses, respectively. Percentage of the apoptotic cells were determined by flow cytometry. The role of FOXO3a was knock-downed using siRNA.
RESULTS: SUN caused suppression of MDA-MB231 cell growth associated with induction of apoptosis, cell cycle arrest, oxidative stress markers and FOXO3a gene. Importantly, silencing of FOXO3a mRNA using siRNA significantly rescued MDA-MB231 cells from SUN-induced cell-proliferative arrest.
CONCLUSION: SUN inhibits TNBC MDA-MB231 cell proliferation through activation of FOXO3a expression. Copyright
© 2016 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved.

Entities:  

Keywords:  FOXO3a; MDA-MB231 cells; Sunitinib; apoptosis; cyclin D; oxidative stress

Mesh:

Substances:

Year:  2016        PMID: 27793938     DOI: 10.21873/anticanres.11200

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  3 in total

Review 1.  CK2 and the Hallmarks of Cancer.

Authors:  May-Britt Firnau; Angela Brieger
Journal:  Biomedicines       Date:  2022-08-16

2.  Decitabine-Induced Changes in Human Myelodysplastic Syndrome Cell Line SKM-1 Are Mediated by FOXO3A Activation.

Authors:  Wen Zeng; Hanjun Dai; Ming Yan; Xiaojun Cai; Hong Luo; Min Ke; Zeming Liu
Journal:  J Immunol Res       Date:  2017-10-16       Impact factor: 4.818

3.  BCL-2 Inhibitor Venetoclax Induces Autophagy-Associated Cell Death, Cell Cycle Arrest, and Apoptosis in Human Breast Cancer Cells.

Authors:  Ali Alhoshani; Fahad O Alatawi; Fawaz E Al-Anazi; Ibraheem M Attafi; Asad Zeidan; Abdelali Agouni; Heba M El Gamal; Licia S Shamoon; Sarah Khalaf; Hesham M Korashy
Journal:  Onco Targets Ther       Date:  2020-12-31       Impact factor: 4.147

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.